Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: A population-based incidence study

AIDS

Volumn 12, Issue 15, 1998, Pages 2067-2072

  Iscovich, José ^a,d   Boffetta, Paolo ^b   Winkelmann, Regina ^b   Brennan, Paul ^b   Azizi, Esther ^c  

^a MINISTRY OF HEALTH   (Israel)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c SHEBA MEDICAL CENTER   (Israel)

^d International Fertility Institute   (Israel)

Author keywords

Classic Kaposi's sarcoma; Epidemiology; Immigrants; Incidence; Israel; Jews

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; ISRAEL; JEW; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL;

EID: 0032558750     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199815000-00019     Document Type: Article

References (43)

1. Dörffel J: Histogenesis of multiple idiopathic hemorrhagic sarcoma of Kaposi. Arch Dermatol Syph 1932, 26:608-634.
2. Rothman S: Some clinical aspects of Kaposi's sarcoma in the European and North American populations. Acta UICC 1962, 18:364-371.
3. Laor T, Schwartz KA: Epidemiologic aspect of American Kaposi's sarcoma. J Surg Oncol 1979, 12:299-303.
4. Ross RK, Casagrande JT, Dworsky RL, Levine A, Mack T: Kaposi's sarcoma in Los Angeles, California. J Natl Cancer Inst 1985, 75:1011-1015.
5. Landman R, Karsenty L, Katz L, Saimol AG: Le sarcome de Kaposi en Isral̂l: donnes épidémiologiques 1960-1980. Bull Soc Path Ex 1984, 77:572-576.
6. Oettlé AG: Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta UICC 1962, 18:330-363.
7. Davies JNP, Elmes, S, Hult MSR, Mtimavalye LAR, Owor R, Shaper I.: Cancer in an African commmunity, 1897-1956. Br Med J 1964, 1:259-264.
8. Slavin G, Cameron H, Singh H: Kaposi's sarcoma in mainland Tanzania: a report of 117 cases. Br J Cancer 1972, 23:349-357.
9. Taylor JF, Smith PG, Hull D, Pike MC: Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br J Cancer 1972, 26:483-497.
10. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW: Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 1993, 54:26-36.
11. Gafa I, Gaĺa R, Dardanoni I.: Il sarcoma di Kaposi a Ragusa e in Sicilia. In: l Réunion du groupe pour l'épidémiologie et l'enregistrement du cancer dans les pays de langue latine (IARC Internal Report). Lyon: International Agency for Research on Cancer; 1984.
12. Dictor M, Attewell R: Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome. Int J Cancer 1988, 42:346-351.
13. Grulich A, Beral V, Swerdlow AJ: Kaposi's sarcoma in England and Wales before the AIDS epidemic. Br J Cancer 1992, 66:1165-1137.
14. Franceschi S, Geddes M: Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori 1995, 81:308-314.
15. Cottoni F, De Marco R, Montesu MA: Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991. Br J Cancer 1996, 72:1132-1133.
16. Hjalgrim H, Melbye M, Pukkala L, et al.: Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic. Br J Cancer 1996, 74:1499-1502.
17. Touloumi G, Kaklamanis L, Potouridou, et al.: The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer 1997, 70:538-541.
18. Penn I: Overview. Kaposi's sarcoma in transplant recipients. Transplantation 1997, 64:669-673.
19. Kinlen LJ, Skeil AGR, Peto J, Doll R: Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979, 2:1461-1466.
20. Rutherford GW, Payne SS, Lemp GF: The epidemiology of AIDS related Kaposi's sarcoma in San Francisco. J AIDS 1990, 3(Suppl):54-60.
21. Beral V: Epidemiology of Kaposi's sarcoma. Cancer Surv 1991, 10:5-22.
22. Chang Y, Cesarman E, Pessin MS, et al.: Identification of herpervirus-like sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
23. Moore PS, Chang Y: Detection of herpesvirus-loke DNA sequences in Kaposi's sarcoma in patients with and without HIV infections. N Ingl J Med 1995, 332:1181-1185.
24. Steinitz R, Parkin D, Young J, Bieber C, Katz L, (Eds): Cancer Incidence in Jewish Migrants to Israel, 1961-1981 (IARC Scientific Publications 98). Lyon: International Agency for Research on Cancer; 1989.
25. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J, (Eds): Cancer Incidence in Five Continents, Vol VI. (IARC Scientific Publications 120). Lyon: International Agency for Research on Cancer; 1992.
26. Word Health Organization: International Classification of Disease in Oncology, Geneva: World Health Organization; 1979.
27. Central Bureau of Statistics: Annual Statistics Abstract of Israel, Series 13-45, 1962-1994. Jerusalem: Central Bureau of Statistics.
28. Breslow N, Day N: Statistical Methods in Cancer Research, Vol II, The Design and Analysis of Cohort Studies. (IARC Scientific Publication 82). Lyon: International Agency for Research on Cancer; 1987.
29. StataCorp: Stata Statistical Software: Release 5.0. College Station, TX: Stata Corporation; 1997.
30. Kaldor JM, Coates M, Vettom L, Taylor R: Epidemiological characteristics of Kaposi's sarcoma prior to the AIDS epidemic. Br J Cancer 1994, 70:674-676.
31. Biggar RJ, Horm J, Fraumeni JF Jr, Greene MH, Goedert JJ: Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-1981. J Natl Cancer Inst 1984, 73:89-94.
32. Geddes M, Franceschi S, Barchielli A, et al.: Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 1994, 69:333-336.
33. Hult MSR: Kaposi's sarcoma. Br Med Bull 1984, 40:355-358.
34. IARC: Human immunodeficiency viruses and human T-cell lymphotropic viruses. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Human, Vol 67. Lyon: International Agency for Research on Cancer; 1996.
35. Doll R, Muir C, Waterhouse J, (EDs): Cancer Incidence in Five Continents, Vol II. Geneva: International Union against Cancer. Berlin: Springer-Verlag; 1970.
36. Waterhouse JAH, Muir C, Correa P, Powell J: Cancer Incidence in Five Continents, Vol III. Lyon: International Agency for Research on Cancer; 1976.
37. van der Esch EP, Muir CS, Nectoux J, et al.: Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991, 47:483-489.
38. Zong JCH, Metroka C, Reitz MS, Nicholas J, Hayward GS: Strain variability among Kaposi sarcoma associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. J Virol 1997, 71:2505-2511.
39. Kinlen IJ: Epidemiology evidence for an infective basis in childhood leukaemia. Br J Cancer 1995, 71:1-5.
40. Davies AM: Migrants and their children in Israel: identification and change. Isr J Med Sci 1971, 7:1342-1347.
41. Chadli A, Rethers I, Landreat A, Habanec B: La physionomie du cancer en Tunisie : étude de 7959 cancers primitifs. Arch Inst Pasteur Tunis 1976, 4:317-423.
42. Marill FG, Sayag J, Hadida E: L'acro-sarcomatose de Kaposi en Algérie. Méd Trop 1973, 33:471-481.
43. Dalgleish AG: Kaposi's sarcoma. Br J Cancer 1991, 64:3-6.